With celebrities singing the praises of full-body MRI scans, a growing number of people are coughing up the cash for ...

Brookhaven resident Daffany Fajardo Murphy doesn’t have an off switch. The corporate vice president, mom of two adult ...

Colorectal cancer was found to be the most common malignancy and cause of death among patients with classic familial adenomatous polyposis.

In just over a year since its US Food and Drug Administration (FDA) approval, pirtobrutinib (Jayprica) has become a standard ...

The internationally renowned Dana-Farber Cancer Institute will operate the cancer clinic now under construction on the Sturdy ...

Dana-Farber Cancer Institute and Boston Children’s Cancer and Blood Disorders Center have received a 4-year, $5 million ...

Study Health announced it will be partnering with Dana-Farber Cancer Institute to provide cancer service at its hospital in ...

Treatment with Rina-S showed antitumor activity in heavily pretreated patients with advanced ovarian cancer, according to the ...

Cabozantinib, an oral tyrosine kinase inhibitor, has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of patients with previously treated advanced neuroendocrine tumors ...

Celebrating 25 years since its founding, Alex’s Lemonade Stand Foundation (ALSF) has announced the funding of two pioneering ...